FALLOPIAN TUBE CANCER
Clinical trials for FALLOPIAN TUBE CANCER explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CANCER trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo drug trial for Tough-to-Treat ovarian cancer halted
Disease control TerminatedThis early-stage trial tested the safety and best dose of a new drug, STRO-002, when given with an existing cancer drug, bevacizumab. It was for people with advanced ovarian, fallopian tube, or primary peritoneal cancer that had come back or stopped responding to standard treatme…
Matched conditions: FALLOPIAN TUBE CANCER
Phase: PHASE1 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Scientists test supercharged immune cells against tough cancers
Disease control TerminatedThis early-stage study tested a new treatment for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has returned or stopped responding to standard therapies. Researchers collected a patient's own immune cells (monocytes), activated them with two drugs…
Matched conditions: FALLOPIAN TUBE CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for women battling Tough-to-Treat ovarian cancer?
Disease control TerminatedThis study tested an experimental drug called luveltamab tazevibulin against standard chemotherapy for women with advanced ovarian cancer that had returned and stopped responding to platinum-based drugs. It aimed to see if the new drug could better control the cancer and improve …
Matched conditions: FALLOPIAN TUBE CANCER
Phase: PHASE2, PHASE3 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Scientists gather cancer fluids in hunt for new treatment clues
Knowledge-focused TerminatedThis study aimed to collect fluid samples from the abdomen or chest and blood from adults with solid tumors. The goal was to analyze these samples to better understand cancer biology. Researchers hoped this knowledge would help develop improved cancer treatments in the future. No…
Matched conditions: FALLOPIAN TUBE CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC